Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Staphylococcus aureus, vancomycin intermediate/resistant |
Duration of hospitalization and upon readmission. |
Discontinuation will be determined by Infection Prevention on a case by case basis. |
|
Carbapenem Resistant Acinetobacter- carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |
|
Carbapenem, cefepime or ceftazidime resistant Pseudomonas aeruginosa- carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |
|
ESBL producer and carbapenemase gene positive |
Duration of hospitalization and upon readmission. |
Isolation may not be removed. The following carbapenemase genes are tested: KPC, NDM, OXA-48, VIM, IMP-1. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Until 5 days after the onset of swelling |
Susceptible HCWs should not provide care if immune caregivers are available. HCWs should use masks regardless of immune status. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Non-tuberculous mycobacteria (atypical), pulmonary or wound | |||
Tuberculosis, active pulmonary or laryngeal |
See Tuberculosis *Patients undergoing invasive procedures that may aerosolize require Airborne Isolation. Contact Infection Prevention. |
Condition | Isolation | Duration of Isolation | Comment |
---|---|---|---|
Duration of illness |